Dermata Therapeutics Inc (DRMA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.06M
Last updated: Nov 17, 2026 at 4:10 PM ET
Dermata Therapeutics Inc (DRMA) Stock Chart
Dermata Therapeutics (DRMA) has a latest price of $0.57 on Nov 17, 2026, 82.0% below its 52-week high of $3.16. Its price fell 81.4% over the past 12 months. The month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 85.3%.
Price Chart
From Aug 2021 to Oct 2026, its highest month-end close was $13,913.04 in Aug 2021 and its lowest $0.78 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart DRMA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for DRMA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 61.2%, and over 6 months it fell 51.7%. The month-end price fell 99.1% over the 3 years through Oct 2026, a compound annual decline of 79.4%.
| Period | Change |
|---|---|
| 1 month | -33.7% |
| 3 months | -61.2% |
| 6 months | -51.7% |
| 12 months | -81.4% |
| 12 months, with dividends | -81.4% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -99.1% | -79.4% |
| 5 years | -100.0% | -85.3% |
Price by Year
Its best calendar year was 2022, when the price fell 76.5%, and its weakest was 2023, when it fell 90.7%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $0.78 | -66.6% |
| 2025 | $2.32 | -82.8% |
| 2024 | $13.50 | -85.2% |
| 2023 | $91.45 | -90.7% |
| 2022 | $981.11 | -76.5% |
Trading Range
The price is 39.4% below its 50-day average of $0.94 and 53.1% below its 200-day average of $1.22.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $0.57 | |
| 52-week high | $3.16 | -82.0% |
| 52-week low | $0.57 | +0.7% |
| 50-day average | $0.94 | -39.4% |
| 200-day average | $1.22 | -53.1% |
Price Risk
Over 3 years, its largest fall from a peak was 99.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.22 |
| Largest fall, 1 year | -81.8% |
| Largest fall, 3 years | -99.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About DRMA
What is DRMA's 1-year price change?
Dermata Therapeutics's price fell 81.4% over the past 12 months. With dividends included, the 12-month total return was -81.4%.
What is DRMA's 5-year price change?
Dermata Therapeutics's month-end price fell 100.0% over the 5 years through Oct 2026, a compound annual decline of 85.3%. These figures leave out dividends.
What is DRMA's 52-week high and low?
Dermata Therapeutics's 52-week high is $3.16 and its 52-week low is $0.57. Its latest price of $0.57 on Nov 17, 2026 is 82.0% below the high.
What is DRMA's beta?
Dermata Therapeutics's 1-year beta against the S&P 500 is 1.22, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 81.8%.
Is the DRMA chart free?
Yes. Advanced Charting for DRMA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
DRMA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors